165 related articles for article (PubMed ID: 31409008)
1. Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma.
Feder S; Kandulski A; Schacherer D; Weiss TS; Buechler C
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31409008
[TBL] [Abstract][Full Text] [Related]
2. Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma.
Imai K; Takai K; Hanai T; Shiraki M; Suzuki Y; Hayashi H; Naiki T; Nishigaki Y; Tomita E; Shimizu M; Moriwaki H
Int J Mol Sci; 2014 Jun; 15(7):11294-306. PubMed ID: 24968270
[TBL] [Abstract][Full Text] [Related]
3. Serum Adiponectin Levels Do Not Distinguish Primary from Metastatic Liver Tumors.
Feder S; Kandulski A; Schacherer D; Weiss TS; Buechler C
Anticancer Res; 2020 Jan; 40(1):143-151. PubMed ID: 31892562
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin.
Grazi GL; Mazziotti A; Legnani C; Jovine E; Miniero R; Gallucci A; Palareti G; Gozzetti G
Liver Transpl Surg; 1995 Jul; 1(4):249-55. PubMed ID: 9346575
[TBL] [Abstract][Full Text] [Related]
5. Association between High Levels of Circulating Chemerin and Colorectal Adenoma in Men.
Yagi M; Sasaki Y; Abe Y; Yaoita T; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kon T; Nishise S; Ueno Y
Digestion; 2020; 101(5):571-578. PubMed ID: 31269491
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis.
Jiao X; Shu G; Liu H; Zhang Q; Ma Z; Ren C; Guo H; Shi J; Liu J; Zhang C; Wang Y; Gao Y
J Histochem Cytochem; 2019 May; 67(5):299-308. PubMed ID: 30633620
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
Julich-Haertel H; Urban SK; Krawczyk M; Willms A; Jankowski K; Patkowski W; Kruk B; Krasnodębski M; Ligocka J; Schwab R; Richardsen I; Schaaf S; Klein A; Gehlert S; Sänger H; Casper M; Banales JM; Schuppan D; Milkiewicz P; Lammert F; Krawczyk M; Lukacs-Kornek V; Kornek M
J Hepatol; 2017 Aug; 67(2):282-292. PubMed ID: 28267620
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Bruckmann A; Hoering M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905933
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
10. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
[TBL] [Abstract][Full Text] [Related]
11. Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases.
Dong H; Tang J; Li LH; Ge J; Chen X; Ding J; Men HT; Luo WX; Du Y; Li C; Zhao F; Chen Y; Cheng K; Liu JY
Asian Pac J Cancer Prev; 2013; 14(2):909-13. PubMed ID: 23621260
[TBL] [Abstract][Full Text] [Related]
12. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
13. Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Buechler C
Anticancer Res; 2018 May; 38(5):2649-2657. PubMed ID: 29715085
[TBL] [Abstract][Full Text] [Related]
14. Comparing prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins glypican-3, Alpha feto protein and carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients.
Abd El Gawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
J Egypt Natl Canc Inst; 2014 Jun; 26(2):79-85. PubMed ID: 24841158
[TBL] [Abstract][Full Text] [Related]
15. Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.
Lee JY; Lee MK; Kim NK; Chu SH; Lee DC; Lee HS; Lee JW; Jeon JY
PLoS One; 2017; 12(5):e0176929. PubMed ID: 28475614
[TBL] [Abstract][Full Text] [Related]
16. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
[No Abstract] [Full Text] [Related]
17. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
18. Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer.
Eichelmann F; Schulze MB; Wittenbecher C; Menzel J; Weikert C; di Giuseppe R; Biemann R; Isermann B; Fritsche A; Boeing H; Aleksandrova K
JAMA Netw Open; 2019 Mar; 2(3):e190896. PubMed ID: 30901045
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
20. An efficient model for auxiliary diagnosis of hepatocellular carcinoma based on gene expression programming.
Zhang L; Chen J; Gao C; Liu C; Xu K
Med Biol Eng Comput; 2018 Oct; 56(10):1771-1779. PubMed ID: 29546505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
